News
Viatris Wins US FDA Approval for RYZUMVI in Presbyopia
Viatris is exploring the possibility of partnering with another company in the United States to commercialise RYZUMVI for presbyopia.
E-MAIL: your-email@mail.com
E-MAIL: your-email@mail.com
Viatris is exploring the possibility of partnering with another company in the United States to commercialise RYZUMVI for presbyopia.
HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.
Contact: +91 9354115542
HealthXploreIndia @2026. All Rights Reserved.
